Viña JR

No ORCID on file · 1 paper in corpus
other 2025
Life (Basel, Switzerland) ·doi:10.3390/life15091454

BACKGROUND: Premenstrual syndrome (PMS) affects 950 million women worldwide. However, conventional pharmacological treatments offer limited improvements. OBJECTIVE: This study aimed to evaluate the effectiveness of the FemmeBalance supplem…